You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

ROXICET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Roxicet, and what generic alternatives are available?

Roxicet is a drug marketed by Hikma and Roxane and is included in three NDAs.

The generic ingredient in ROXICET is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Summary for ROXICET
US Patents:0
Applicants:2
NDAs:3
Clinical Trials: 1
Formulation / Manufacturing:see details
DailyMed Link:ROXICET at DailyMed
Drug patent expirations by year for ROXICET
Drug Sales Revenue Trends for ROXICET

See drug sales revenues for ROXICET

Recent Clinical Trials for ROXICET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)N/A
University of KentuckyN/A
Merck Sharp & Dohme Corp.N/A

See all ROXICET clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ROXICET

US Patents and Regulatory Information for ROXICET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma ROXICET acetaminophen; oxycodone hydrochloride SOLUTION;ORAL 089351-001 Dec 3, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma ROXICET acetaminophen; oxycodone hydrochloride TABLET;ORAL 087003-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roxane ROXICET 5/500 acetaminophen; oxycodone hydrochloride TABLET;ORAL 089775-001 Jan 12, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.